Topical Steroid Formulation and Wet Wraps

• Status: Completed
• Trial end date: 2018-06-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to

1. Compare efficacy of 0.1% triamcinolone containing wet wrap as an ointment or as a cream formulation in patients with moderate to severe atopic dermatitis

2. The relative patient/subject acceptance and adherence will also be compared between the two wet wrap types

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Seton Healthcare Family
• Treatments: Triamcinolone; Triamcinolone Acetonide; Triamcinolone diacetate; Triamcinolone hexacetonide

Criteria

Inclusion Criteria:

1. Patients between the ages of 3-17 experiencing a symmetric, bilateral flare of atopic dermatitis

2. The flares must reach a certain threshold for inclusion based on the investigator's global assessment scale

Exclusion Criteria:

1. Systemic infection or bacterial skin infections

2. Eczema herpeticum

3. Evidence of suppression of the Hypothalamic-Pituitary-Adrenal axis

4. Non-English or Non-Spanish speaking